M., Lee, K
Additionally, if the 2.4-mg maintenance dose is not tolerated, the dose may be temporarily reduced to 1.7 mg for up to 4 weeks
Mongioi L, Calogero AE, Vicari E, et al
It helps to neutralize harmful substances, toxins, and heavy metals in the body, making them easier to eliminate
REDEFINE 2 ClinicalTrials.gov number, NCT05394519.) Cagrilintide-Semaglutide for Overweight and Diabetes In this phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide-semaglutide resulted in a significantly lower body weight than placebo at 68 weeks.
They should be stored at Controlled Room Temperature (20C25C / 68F77F) away from direct sunlight